Samuel J. Klempner

4 articles listing Samuel J. Klempner in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance Nature Communications
2. Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B Nature Communications
3. Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies Nature Communications
4. DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B Nature Communications